Lataa...
The Development of Hypogonadotropic Hypogonadism After Starting Low Dose Mifepristone for Cushing’s Syndrome
Background: Mifepristone is an antiprogesterone that has been studied in females and has shown central effects including suppressing LH surges. There is a paucity of information about how it effects males. Clinical Case: 65-year-old male with bilateral adrenal macronodular hyperplasia noted on a pas...
Tallennettuna:
| Julkaisussa: | J Endocr Soc |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8090319/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.325 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|